$61.54 +0.64 (%) AbbVie Inc - New York Stock Exchange, Inc.

Dec. 9, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Biotechs Unhinged By Tough Pricing Talk

    TalkMarkets | Dec. 8, 2016 | 23:04PM EST
  2. Actelion Remains In M&A Spotlight, ASH Data In Focus

    TalkMarkets | Dec. 7, 2016 | 18:01PM EST
  3. Dividend Income Update November 2016

    TalkMarkets | Dec. 4, 2016 | 21:02PM EST
  4. Guide to American Funds Investment Company of America R2 Fund (RICBX)

    TalkMarkets | Dec. 4, 2016 | 04:08AM EST
  5. OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix Win

    Investors Business Daily | Dec. 1, 2016 | 16:21PM EST
  6. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  7. December 2016 Stock Considerations

    TalkMarkets | Nov. 28, 2016 | 10:06AM EST
  8. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
  9. Pfizer: How a 15% Decline is a Gift to Income Investors

    TalkMarkets | Nov. 20, 2016 | 11:12AM EST
  10. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  11. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  12. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  13. On The Fly: Top stock stories for Monday

    TalkMarkets | Nov. 7, 2016 | 18:48PM EST
  14. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  15. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  16. Dividend Aristocrats In Focus Part 29: Abbott Laboratories

    TalkMarkets | Nov. 3, 2016 | 11:54AM EST
  17. Dividend Aristocrats In Focus Part 28: Abbvie

    TalkMarkets | Nov. 3, 2016 | 10:25AM EST
  18. November 2016 Stock Considerations

    TalkMarkets | Nov. 1, 2016 | 09:38AM EST
  19. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  20. Recent Stock Purchase II October 2016

    TalkMarkets | Oct. 29, 2016 | 11:19AM EST
  21. Hershey Co. Rises On Earnings, AbbVie Inc. Declines On Sales Miss

    TalkMarkets | Oct. 28, 2016 | 10:16AM EST
  22. How to Play Hot Tech IPOs With ETFs

    TalkMarkets | Oct. 21, 2016 | 18:39PM EST
  23. Big Pharma’s Big Biotech Problem

    Dividend.com | Oct. 12, 2016 | 08:00AM EST
  24. Stocks Going Ex Dividend The Second Week Of October

    TalkMarkets | Oct. 9, 2016 | 18:47PM EST
  25. AbbVie Inc. Company Leads 33 Stocks Going Ex-Dividend Next Week

    Dividend.com | Oct. 6, 2016 | 08:00AM EST
  26. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets | Oct. 5, 2016 | 23:06PM EST
  27. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  28. Gilead 'Paralyzed' On Likely Hepatitis C Share Loss To AbbVie, Merck

    IBD | Sep. 27, 2016 | 15:28PM EST
  29. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  30. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com | Sep. 12, 2016 | 11:00AM EST
  31. Don’t Worry, AbbVie Will Be Just Fine

    Dividend.com | Aug. 31, 2016 | 08:00AM EST
  32. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  33. Trending on Dividend.com: Technology Stocks Gain Visibility as Earnings Season Is Underway

    Dividend.com | Jul. 29, 2016 | 11:00AM EST
  34. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 09:46AM EST
  35. Exxon, Chevron, Merck Earnings, Q2 GDP Data On Tap Friday

    Investors Business Daily | Jul. 28, 2016 | 16:21PM EST
  36. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 07:00AM EST
  37. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 12:57PM EST
  38. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  39. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  40. IPO Indexes Weak, But A Few Leaders Outperform

    IBD | Feb. 10, 2016 | 16:42PM EST
  41. The Generic Drug Battle

    Benzinga | Feb. 10, 2016 | 09:13AM EST
  42. Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

    Benzinga | Feb. 8, 2016 | 15:27PM EST
  43. Benzinga's Top Initiations

    Benzinga | Feb. 5, 2016 | 09:32AM EST
  44. Is Big Pharma Hinting At A SMID-Cap Biotech Rally?

    Benzinga | Feb. 3, 2016 | 13:16PM EST
  45. Earnings Recap For January 29

    Benzinga | Jan. 29, 2016 | 17:36PM EST
  46. Biogen Drug 'Increasingly Vulnerable,' Analyst Warns After Speaking With MS Expert

    Benzinga | Jan. 29, 2016 | 09:29AM EST
  47. AbbVie Falling After Q4 Report, 2016 Guidance Affirmation

    Benzinga | Jan. 29, 2016 | 08:14AM EST
  48. Earnings Scheduled For January 29, 2016

    Benzinga | Jan. 29, 2016 | 04:05AM EST
  49. Abbvie Announces Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA

    Benzinga | Jan. 28, 2016 | 04:29AM EST
  50. US Big Pharma: What To Watch For In Q4 Results

    Benzinga | Jan. 25, 2016 | 11:16AM EST
Trading Center